| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| Ronald Hao Xi EdeNon-Executive Director | 7.04K | -- | Derivatives acquired | 2.38M | 0.14% | ||
| Charles Leland CooneyIndependent Non-Executive Director | -38.63K | 107.99 | Sold | 151.80K | 0.01% | ||
| Charles Leland CooneyIndependent Non-Executive Director | 38.63K | -- | Derivatives exercised | 190.42K | 0.01% | ||
| Ronald Hao Xi EdeNon-Executive Director | -752.38K | 88.50 | Sold | 4.92M | 0.28% | ||
| Ronald Hao Xi EdeNon-Executive Director | 752.38K | -- | Derivatives exercised | 5.67M | 0.33% | ||
| Ronald Hao Xi EdeNon-Executive Director | -1.88M | 87.53 | Sold | 5.67M | 0.33% | ||
| Ronald Hao Xi EdeNon-Executive Director | 1.88M | -- | Derivatives exercised | 7.56M | 0.43% |
Changes in interests filed with HKEX by directors and chief executives. The bought/sold totals count long-position purchases and sales only; option exercises, grants and other events are left out.
| Shareholder | |||
|---|---|---|---|
| De-Chao Michael YuExecutive Director | 7.49% | 130.21M | |
| Qian ZhangExecutive Director | 0.41% | 7.14M | |
| Ronald Hao Xi EdeNon-Executive Director | 0.14% | 2.38M | |
| Zieziula Gary Joseph | 0.03% | 469.73K | |
| Charles Leland CooneyIndependent Non-Executive Director | 0.01% | 151.80K | |
| Joyce I-Yin HsuIndependent Non-Executive Director | 0.01% | 151.33K | |
| Shuyun ChenIndependent Non-Executive Director | <0.01% | 67.25K | |
| 陳凱先 | <0.01% | 46.02K | |
| Stephen A. SherwinIndependent Non-Executive Director | <0.01% | 31.13K |
From the HKEXnews Disclosure of Interests complete list of directors: each director's long position after their latest filing.
This page shows share dealings filed by INNOVENT BIO (01801) directors and chief executives over the past year (date, shares, price, type and holding afterwards) with bought and sold totals, and each director's current holding. Data comes from the HKEXnews Disclosure of Interests (DI) section.

